Published in Immunogenetics on July 27, 2010
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet (2011) 3.20
Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science (2017) 2.70
Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort. Clin Gastroenterol Hepatol (2015) 1.44
The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls. Gastroenterology (2011) 1.18
Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One (2011) 1.10
Clinical practice : coeliac disease. Eur J Pediatr (2012) 0.92
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP). J Neuroinflammation (2012) 0.91
Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol (2012) 0.90
Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes. Funct Integr Genomics (2012) 0.88
Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements. PLoS One (2015) 0.85
Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J Gastroenterol (2014) 0.84
Serological testing for celiac disease in adults. United European Gastroenterol J (2013) 0.83
The management of refractory coeliac disease. Ther Adv Chronic Dis (2013) 0.83
The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition. Pediatr Nephrol (2017) 0.83
Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens. Nat Rev Rheumatol (2015) 0.83
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop. J Immunol Res (2015) 0.83
Improved xenobiotic metabolism and reduced susceptibility to cancer in gluten-sensitive macaques upon introduction of a gluten-free diet. PLoS One (2011) 0.82
Risk factors for celiac disease. Ital J Pediatr (2015) 0.80
The Spectrum of Differences between Childhood and Adulthood Celiac Disease. Nutrients (2015) 0.80
Is enteroscopy necessary for diagnosis of celiac disease? World J Gastroenterol (2012) 0.80
Coeliac disease and gluten-related disorders in childhood. Nat Rev Gastroenterol Hepatol (2015) 0.80
No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. World J Gastroenterol (2012) 0.80
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78
Novel trends in celiac disease. Cell Mol Immunol (2011) 0.78
Celiac disease in adult patients: specific autoantibodies in the diagnosis, monitoring, and screening. Autoimmune Dis (2014) 0.78
Epithelial transport of immunogenic and toxic gliadin peptides in vitro. PLoS One (2014) 0.78
Distal duodenum versus duodenal bulb: intraepithelial lymphocytes have something to say in celiac disease diagnosis. Dig Dis Sci (2014) 0.76
Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease. Clin Exp Immunol (2014) 0.75
A biased view toward celiac disease. Mucosal Immunol (2016) 0.75
Improving outcomes of refractory celiac disease - current and emerging treatment strategies. Clin Exp Gastroenterol (2016) 0.75
New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity. J Allergy Clin Immunol (2015) 0.75
Immunopathogenesis and therapeutic approaches in pediatric celiac disease. Expert Rev Clin Immunol (2016) 0.75
Comparison of four functionalization methods of gold nanoparticles for enhancing the enzyme-linked immunosorbent assay (ELISA). Beilstein J Nanotechnol (2017) 0.75
Coeliac screening in a Scottish cohort of children with type 1 diabetes mellitus: is DQ typing the way forward? Arch Dis Child (2015) 0.75
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele. Front Oncol (2014) 0.75
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04
Celiac disease. N Engl J Med (2007) 10.98
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet (2007) 8.50
Structural basis for gluten intolerance in celiac sprue. Science (2002) 8.16
Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet (2008) 7.63
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol (2003) 6.05
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med (1998) 5.25
Interleukin 15: biology and relevance to human disease. Blood (2001) 4.47
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity (2004) 4.36
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30
Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr (1953) 3.92
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet (2003) 3.78
Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol (2006) 3.55
The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology (2005) 3.33
The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev (1999) 3.21
HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol (2003) 3.17
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest (1972) 3.09
Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology (2003) 3.05
Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology (2002) 2.95
Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol (1998) 2.88
Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut (2009) 2.50
Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med (2002) 2.49
Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet (1975) 2.41
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology (2008) 2.39
The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A (2003) 2.30
IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev (2006) 2.29
Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology (2003) 2.23
Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med (2006) 2.03
Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology (2006) 2.01
Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut (2005) 2.00
Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A (1998) 1.99
Clinical testing of gliadin fractions in coeliac patients. Clin Sci (Lond) (1984) 1.93
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut (2007) 1.92
Wheat peptide challenge in coeliac disease. Lancet (1994) 1.88
HLA-DW3 associated with coeliac disease. Lancet (1976) 1.79
Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet (2010) 1.71
Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology (1998) 1.71
A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology (2003) 1.69
Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol (1999) 1.68
Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One (2008) 1.67
HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest (2006) 1.66
Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol (2009) 1.65
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res (2005) 1.63
Refractory coeliac disease. Best Pract Res Clin Gastroenterol (2005) 1.61
Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut (2005) 1.55
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52
A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity (2007) 1.46
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med (2007) 1.43
The molecular basis for oat intolerance in patients with celiac disease. PLoS Med (2004) 1.40
Genetics in coeliac disease. Best Pract Res Clin Gastroenterol (2005) 1.37
Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol (2006) 1.37
Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology (2000) 1.33
Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology (2009) 1.32
Genetic background of celiac disease and its clinical implications. Am J Gastroenterol (2008) 1.26
Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology (2007) 1.25
Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol (2009) 1.22
Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology (1998) 1.21
HLA related genetic risk for coeliac disease. Gut (2007) 1.16
Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. Immunogenetics (1997) 1.15
Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens (1997) 1.11
Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin Chem (2008) 1.07
Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann Hum Genet (2001) 0.99
Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology (2003) 0.96
Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue. Immunol Rev (2007) 0.93
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood (2008) 0.88
Phenotypic characterization of CD3-7+ cells in developing human intestine and an analysis of their ability to differentiate into T cells. J Immunol (2005) 0.87
Interleukin 21 up-regulates perforin-mediated cytotoxic activity of human intra-epithelial lymphocytes. Immunology (2009) 0.81
Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for coeliac disease? Gut (2008) 0.80
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut (2010) 3.09
The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology (2002) 2.91
Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology (2005) 2.66
Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med (2002) 2.49
Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med (2014) 2.39
The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A (2003) 2.30
Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology (2003) 2.23
The ubiquitin-domain protein HERP forms a complex with components of the endoplasmic reticulum associated degradation pathway. J Mol Biol (2005) 2.04
Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics (2012) 1.79
Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology (2002) 1.72
Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes. BMC Genomics (2006) 1.70
Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol Gastrointest Liver Physiol (2006) 1.62
KIR-HLA intercourse in HIV disease. Trends Microbiol (2008) 1.55
Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut (2012) 1.52
Intolerance of celiac disease patients to bovine milk is not due to the presence of T-cell stimulatory epitopes of gluten. Nutrition (2008) 1.45
Celiac disease--sandwiched between innate and adaptive immunity. Hum Immunol (2006) 1.44
The molecular basis for oat intolerance in patients with celiac disease. PLoS Med (2004) 1.40
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med (2006) 1.17
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol (2013) 1.14
Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol (2004) 1.13
A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med (2003) 1.10
Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2. J Immunol (2008) 1.08
AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz. Proc Natl Acad Sci U S A (2010) 1.04
A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease. PLoS One (2010) 1.02
Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity (2012) 1.01
Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands. J Immunol (2004) 1.01
Functional analysis of killer Ig-like receptor-expressing cytomegalovirus-specific CD8+ T cells. J Immunol (2009) 1.00
Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol (2009) 0.97
T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics (2005) 0.96
HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides. J Immunol (2002) 0.96
Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells. Gastroenterology (2011) 0.96
Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8β transdimer. J Immunol (2011) 0.95
Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire. J Biol Chem (2011) 0.94
Functional killer Ig-like receptors on human memory CD4+ T cells specific for cytomegalovirus. J Immunol (2009) 0.91
Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 0.91
Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation. BMC Genomics (2012) 0.91
The PreventCD Study design: towards new strategies for the prevention of coeliac disease. Eur J Gastroenterol Hepatol (2010) 0.90
Origin and immunophenotype of aberrant IEL in RCDII patients. Mol Immunol (2012) 0.90
Validation of a new enzyme-linked immunosorbent assay to detect the triggering proteins and peptides for celiac disease: interlaboratory study. J AOAC Int (2012) 0.89
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood (2008) 0.88
Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Inflamm Bowel Dis (2011) 0.88
The Ethiopian cereal tef in celiac disease. N Engl J Med (2005) 0.88
The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR. Immunology (2010) 0.87
Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane. Eur J Immunol (2004) 0.86
Fine specificity of monoclonal antibodies against celiac disease-inducing peptides in the gluteome. Am J Clin Nutr (2008) 0.86
Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect. Scand J Gastroenterol (2009) 0.84
Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. Am J Pathol (2007) 0.84
No genetic association of the human prolyl endopeptidase gene in the Dutch celiac disease population. Am J Physiol Gastrointest Liver Physiol (2005) 0.84
Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies. J Immunol (2005) 0.83
Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Invest Ophthalmol Vis Sci (2009) 0.82
The limited storage capacity of gonadal adipose tissue directs the development of metabolic disorders in male C57Bl/6J mice. Diabetologia (2015) 0.82
Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule. Immunogenetics (2008) 0.82
Gluten peptides and celiac disease. Science (2003) 0.82
Enzymatic gluten detoxification: the proof of the pudding is in the eating! Trends Biotechnol (2006) 0.82
Gluten tolerance in adult patients with celiac disease 20 years after diagnosis? Eur J Gastroenterol Hepatol (2008) 0.81
Cutting edge: killer Ig-like receptors mediate "missing self" recognition in vivo. J Immunol (2009) 0.81
Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation. Int Immunol (2007) 0.80
Tef in the diet of celiac patients in The Netherlands. Scand J Gastroenterol (2008) 0.80
Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule. Mol Immunol (2009) 0.80
Tissue transglutaminase: master regulator of celiac disease? J Pediatr Gastroenterol Nutr (2003) 0.79
Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with celiac disease. Bioorg Med Chem (2007) 0.78
HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model. J Immunol (2013) 0.78
Therapy in RCDII: Rationale for Combination Strategies? Dig Dis (2015) 0.78
DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients. J Immunol (2011) 0.77
Design of new high-affinity peptide ligands for human leukocyte antigen-DQ2 using a positional scanning peptide library. Hum Immunol (2010) 0.77
The million-dollar question: is "gluten-free" food safe for patients with celiac disease? Am J Clin Nutr (2012) 0.77
Successful treatment of coeliac disease by allogeneic haematopoietic stem cell transplantation. J Pediatr Gastroenterol Nutr (2010) 0.76
Unique peptide-binding motif for Mamu-B*037:01: an MHC class I allele common to Indian and Chinese rhesus macaques. Immunogenetics (2013) 0.75
Pathophysiology of celiac disease. J Pediatr Gastroenterol Nutr (2014) 0.75
Screening for unrecognized coeliac disease in subfertile couples. Scand J Gastroenterol (2011) 0.75
Anticytomegalovirus seropositivity in rheumatoid arthritis is not associated with the presence of severe extraarticular complications: comment on the article by Pierer et al. Arthritis Rheum (2012) 0.75
Celiac disease: past, present, and future challenges: dedicated to the memory of our friend and colleague, Prof David Branski (1944-2013). J Pediatr Gastroenterol Nutr (2014) 0.75
Genetic and functional analysis of pyroglutamyl-peptidase I in coeliac disease. Eur J Gastroenterol Hepatol (2006) 0.75
Mannosylated self-peptide inhibits the development of experimental autoimmune encephalomyelitis via expansion of nonencephalitogenic T cells. J Leukoc Biol (2008) 0.75
CyteGuide: Visual Guidance for Hierarchical Single-Cell Analysis. IEEE Trans Vis Comput Graph (2017) 0.75